USPTO serial 90327638
Reviewed by CopyMark Law Group
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Deadline: August 17th, 2027
CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.
CellOxess LLC
Ewing, NJ, US
CellOxess LLC
Ewing, NJ, US
CellOxess LLC
Ewing, NJ, US
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Nutraceuticals for the treatment of Oxidative Stress and DNA damage; Nutraceuticals for use as a dietary supplement; Nutraceuticals for use as a dietary supplement for pre- conception fertility enhancement in men and support of female reproductive health before, during and after pregnancy | ACTIVE | Jan 5, 2015 |
| Date | Code | Event |
|---|---|---|
| Aug 17, 2026 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Aug 17, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER |
| Jun 1, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Jun 1, 2021 | PUBO | PUBLISHED FOR OPPOSITION |
| May 12, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Apr 29, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Apr 29, 2021 | DOCK | ASSIGNED TO EXAMINER |
| Jan 23, 2021 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Jan 22, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Nov 21, 2020 | NWAP | NEW APPLICATION ENTERED |